SCOPUS 정보 검색 플랫폼

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 2, 2008, Pages 194-197

Nonprofit biomedical companies

(3) Conti, R M a Meltzer, D O a Ratain, M J b

a UNIVERSITY OF CHICAGO (United States)

b UNIVERSITY OF CHICAGO (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; BIOTECHNOLOGICAL PRODUCTION; CANCER DIAGNOSIS; CANCER THERAPY; DEVELOPED COUNTRY; FUNDING; INVESTMENT; MARKET; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; PROFIT; REIMBURSEMENT; SHORT SURVEY;

BIOMEDICAL RESEARCH; BIOMEDICAL TECHNOLOGY; DEVELOPED COUNTRIES; HEALTH CARE SECTOR; HUMANS; ORGANIZATIONS, NONPROFIT; RESEARCH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 49149092554 PISSN: 00099236 EISSN: 15326535 Source Type: Journal
DOI: 10.1038/clpt.2008.123 Document Type: Short Survey

Times cited : (5)

References (10)

1
- 49149126624
- Accessed 28 April 2008
- BioWorld. 〈http://www.bioworld.com〉 (2008). Accessed 28 April 2008.
- (2008) BioWorld

2
- 33645675960
- Estimating the cost of new drug development: Is it really $802 million?
- Adams, C.P. & Brantner, V.V. Estimating the cost of new drug development: is it really $802 million? Health Affairs 25, 420-428 (2006).
- (2006) Health Affairs , vol.25 , pp. 420-428
- Adams, C.P.¹ Brantner, V.V.²

3
- 40049110428
- Drug approvals and failures: Implications for alliances
- Czerepak, A. & Ryser S. Drug approvals and failures: implications for alliances. Nat. Rev. Drug Discov. 7, 197-198 (2008).
- (2008) Nat. Rev. Drug Discov , vol.7 , pp. 197-198
- Czerepak, A.¹ Ryser, S.²

4
- 49149093974
- National Science Foundation
- National Science Foundation. Science and Technology Indicators 2008, Chapter 6: Industry, Technology, and the Global Marketplace 〈http://www. nsf.gov/statistics/seind08/c6/c6h.htm〉 (2008).
- (2008) Science and Technology Indicators 2008, Chapter 6: Industry, Technology, and the Global Marketplace

5
- 38349144393
- Obstacles and opportunities in new drug development
- Kaitin, K.I. Obstacles and opportunities in new drug development. Clin. Pharmacol. Ther. 83, 210-212 (2008).
- (2008) Clin. Pharmacol. Ther , vol.83 , pp. 210-212
- Kaitin, K.I.¹

6
- 33847391115
- GAO-07-49, pdf〉 November
- US Government Accountability Office. New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts. GAO-07-49 〈http://www.gao.gov/new.items/d0749. pdf〉 (November 2006).
- (2006) New Drug Development: Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts

7
- 23044507037
- Oxymoron no more: The potential of nonprofit drug companies to deliver promise of medicines for the developing world
- Hale, V.G., Woo, K & Levens Lipton, H. Oxymoron no more: the potential of nonprofit drug companies to deliver promise of medicines for the developing world. Health Affairs 24, 1057-1062 (2005).
- (2005) Health Affairs , vol.24 , pp. 1057-1062
- Hale, V.G.¹ Woo, K.² Levens Lipton, H.³

8
- 44649165634
- Yin, W. Market incentives and pharmaceutical innovation. J. Health Econ., published online 17 February 2008. (doi:10.1016/j.jhealeco.2008.01. 002).
- Yin, W. Market incentives and pharmaceutical innovation. J. Health Econ., published online 17 February 2008. (doi:10.1016/j.jhealeco.2008.01. 002).

9
- 33846995628
- Economics of new oncology drug development
- DiMasi, J.A. & Grabowski, H.G. Economics of new oncology drug development. J. Clin. Oncol. 25, 209-216 (2007).
- (2007) J. Clin. Oncol , vol.25 , pp. 209-216
- DiMasi, J.A.¹ Grabowski, H.G.²

10
- 49149117151
- Association for Healthcare Philanthropy. Report on Giving USA, 2006 [compact disc]. Falls Church, VA.
- Association for Healthcare Philanthropy. Report on Giving USA, 2006 [compact disc]. Falls Church, VA.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.